Related Experiment Video
Updated: Jun 18, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study
Yi-Ting Huang1,2, Yao-Chun Hsu3,4,5,6, Hwai-I Yang7,8,9,10
1Institute of Statistical Science, Academia Sinica.
Insights
Hepatitis C virus (HCV) infection causes mortality through both liver and non-liver diseases. Understanding these pathways, including septicemia and renal disease, is key to reducing preventable deaths from HCV.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Background:
- Hepatitis C virus (HCV) infection is a systemic illness with unclear mortality mediation pathways.
- Quantifying the roles of intrahepatic and extrahepatic diseases in HCV-induced mortality is crucial for public health resource allocation.
Purpose of the Study:
- To comprehensively quantify the extent to which intrahepatic and extrahepatic diseases mediate mortality in Hepatitis C virus (HCV) infected individuals.
Main Methods:
- A community-based cohort study in Taiwan with over 25 years of follow-up.
- Linking cohort data with Taiwan's National Health Insurance Research Database.
- Employing causal mediation analyses to assess 34 candidate diseases' mediation effects on HCV-related mortality.
Main Results:
- Intrahepatic diseases mediated 54.1% of HCV-induced mortality (e.g., liver cirrhosis, liver cancer).
- Extrahepatic diseases mediated 45.9%, notably septicemia (25.2%), renal disease (16.7%), and blood/immune diseases (12.2%).
- A dose-response relationship between HCV viral load and mortality mediation was observed.
Conclusions:
- Both intrahepatic and extrahepatic conditions significantly contribute to Hepatitis C virus (HCV)-induced mortality.
- Findings highlight the systemic impact of HCV and support viral load as a key factor in mortality mediation.
Background:
Hepatitis C virus (HCV) infection is a systemic disease. However, the relative contribution of intrahepatic and extrahepatic diseases to mediating HCV-induced mortality is unclear, albeit critical in resource allocation for reducing preventable deaths. To this end, this study comprehensively quantified the extent to which intrahepatic and extrahepatic diseases mediate HCV-induced mortality.
Methods:
A community-based cohort study with >25 years of follow-up was conducted in Taiwan. HCV infection was profiled by antibodies against HCV and HCV RNA in participants' serum samples. The cohort data were linked to Taiwan's National Health Insurance Research Database to determine the incidences of potential mediating diseases and mortality. We employed causal mediation analyses to estimate the mediation effects of HCV on mortality in relation to the incidences of 34 candidate diseases.
Results:
In 18,972 participants with 934 HCV infection, we observed that 54.1% of HCV-induced mortality was mediated by intrahepatic diseases, such as liver cirrhosis and liver cancer, and 45.9% of mortality was mediated by extrahepatic diseases. The major extrahepatic mediating diseases included septicemia (estimated proportion of HCV-induced mortality mediated through the disease: 25.2%), renal disease (16.7%), blood/immune diseases (12.2%), gallbladder diseases (9.7%), and endocrine diseases (9.6%). In women, hypertension (20.0%), metabolic syndrome (18.9%), and type 2 diabetes (17.0%) also mediated HCV-induced mortality. A dose-response relationship of HCV viral load was further demonstrated for the mediation effect.
Conclusion:
Both intrahepatic and extrahepatic manifestations mediated approximately half of HCV-induced mortality. The mediation mechanisms are supported by a dose-response relationship of HCV viral load.
Related Concept Videos
Causality in Epidemiology
Censoring Survival Data
Criteria for Causality: Bradford Hill Criteria - II
Introduction to Epidemiology
Criteria for Causality: Bradford Hill Criteria - I
Assumptions of Survival Analysis

